TrialAnnals of surgical oncology2023

Local-Regional Recurrence After Neoadjuvant Endocrine Therapy: Data from ACOSOG Z1031 (Alliance), a Randomized Phase 2 Neoadjuvant Comparison Between Letrozole, Anastrozole, and Exemestane for Postmenopausal Women with Estrogen Receptor-Positive Clinical Stage 2 or 3 Breast Cancer.

Kelly K Hunt et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.